299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03058068 (ClinicalTrials.gov)	December 2020	6/2/2017	Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis	A Phase I, Randomized and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis - HAPI	Cystic Fibrosis	Biological: Allo-hMSCs;Biological: Placebo	Joshua M Hare	NULL	Withdrawn	20 Years	45 Years	All	0	Phase 1	United States
2	NCT02866721 (ClinicalTrials.gov)	August 2016	7/8/2016	Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis	A Phase I, Single Center, Open Label, Single Dose, Dose Escalation Study Assessing the Safety and Tolerability of AllogeneiC MEsenchymAl Stem CEll Infusion in Adults With Cystic Fibrosis-CEASE CF	Cystic Fibrosis	Biological: Mesenchymal Stem Cells	University Hospitals Cleveland Medical Center	Case Western Reserve University;Cystic Fibrosis Foundation	Completed	18 Years	N/A	All	14	Phase 1	United States
3	NCT02625246 (ClinicalTrials.gov)	February 4, 2016	4/12/2015	Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis	A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell (hMSC) Infusion in Patients With Non-Cystic Fibrosis Bronchiectasis	Bronchiectasis	Biological: hMSCs	Marilyn Glassberg	NULL	Completed	30 Years	87 Years	All	6	Phase 1	United States